1. Molecular analysis of sentinel lymph nodes in patients with breast cancer using one-step nucleic acid amplification (OSNA): Does not lead to overtreatment in the current era of de-escalating axillary management
    K.F.H. Hintzen et al, 2020, Surgical Oncology CrossRef
  2. One‐step nucleic acid amplification CK19 copy number for sentinel node biopsy in breast cancer: Identification of new cutoffs to predict nonsentinel axillary node involvement
    Giulio Cuffolo et al, 2020, The Breast Journal CrossRef
  3. Prediction of Non-sentinel Lymph Node Metastasis by One-step Nucleic Acid Amplification of Sentinel Lymph Nodes in Luminal Breast Cancer
    Tomoo INOUE et al, 2022, Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) CrossRef
  4. External validation of a prognostic model based on total tumor load of sentinel lymph node for early breast cancer patients
    Antonio Piñero-Madrona et al, 2020, Breast Cancer Research and Treatment CrossRef
  5. Intraoperative Pathological Examination of Breast Lesions
    Ekrem Yavuz et al, 2019, Breast Cancer CrossRef
  6. Can axillary lymphadenectomy be avoided in breast cancer with positive sentinel lymph node biopsy? Predictors of non-sentinel lymph node metastasis
    Sonia Martinez Alcaide et al, 2022, Archives of Gynecology and Obstetrics CrossRef
  7. Impact of analysis of the sentinel lymph node by one-step nucleic acid amplification (OSNA) compared to conventional histopathology on axillary and systemic treatment: data from the Dutch nationwide cohort of breast cancer patients
    Elisabeth R. M. van Haaren et al, 2023, Breast Cancer Research and Treatment CrossRef
  8. Can one-step nucleic acid amplification assay predict four or more positive axillary lymph node involvement in breast cancer patients: a single-centre retrospective study
    R Kenny et al, 2022, The Annals of The Royal College of Surgeons of England CrossRef
  9. Predictive and prognostic value of total tumor load in sentinel lymph nodes in breast cancer patients after neoadjuvant treatment using one-step nucleic acid amplification: the NEOVATTL study
    B. Vieites et al, 2021, Clinical and Translational Oncology CrossRef